Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2018, Article ID 3829768, 13 pages
https://doi.org/10.1155/2018/3829768
Research Article

Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study

Department of Physics, Fu-Jen Catholic University, New Taipei City 24205, Taiwan

Correspondence should be addressed to Yung-Shin Sun; wt.ude.ujf.liam@759980

Received 25 October 2017; Revised 25 December 2017; Accepted 30 January 2018; Published 22 February 2018

Academic Editor: Marta Parazzini

Copyright © 2018 Yung-Shin Sun. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. A. Kohler, E. Ward, B. J. McCarthy et al., “Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system,” Journal of the National Cancer Institute, vol. 103, no. 9, pp. 714–736, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Young, A. Jamshidi, G. Davis, and J. H. Sherman, “Current trends in the surgical management and treatment of adult glioblastoma,” Annals of Translational Medicine, vol. 3, no. 9, p. 121, 2015. View at Google Scholar
  3. C. Gzell, M. Back, H. Wheeler, D. Bailey, and M. Foote, “Radiotherapy in Glioblastoma: the Past, the Present and the Future,” Clinical Oncology, vol. 29, no. 1, pp. 15–25, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Khosla, “Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma,” Annals of Translational Medicine, vol. 4, no. 3, p. 54, 2016. View at Google Scholar
  5. S. Kuramitsu, A. Yamamichi, F. Ohka, K. Motomura, M. Hara, and A. Natsume, “Adoptive immunotherapy for the treatment of glioblastoma: Progress and possibilities,” Immunotherapy, vol. 8, no. 12, pp. 1393–1404, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. A. A. Thomas, M. S. Ernstoff, and C. E. Fadul, “Immunotherapy for the treatment of glioblastoma,” Cancer Journal, vol. 18, no. 1, pp. 59–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Kwiatkowska, M. Nandhu, P. Behera, E. Chiocca, and M. Viapiano, “Strategies in Gene Therapy for Glioblastoma,” Cancers, vol. 5, no. 4, pp. 1271–1305, 2013. View at Publisher · View at Google Scholar
  8. R. Stupp, W. P. Mason, M. J. van den Bent et al., “Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma,” The New England Journal of Medicine, vol. 352, no. 10, pp. 987–996, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Zhao, J. V. Forrester, and C. D. Mccaig, “A small, physiological electric field orients cell division,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 96, no. 9, pp. 4942–4946, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Nuccitelli, “A role for endogenous electric fields in wound healing,” Current Topics in Developmental Biology, vol. 58, pp. 1–26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-S. Sun, S.-W. Peng, K.-H. Lin, and J.-Y. Cheng, “Electrotaxis of lung cancer cells in ordered three-dimensional scaffolds,” Biomicrofluidics, vol. 6, no. 1, Article ID 014102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Y.-S. Sun, S.-W. Peng, and J.-Y. Cheng, “In vitro electrical-stimulated wound-healing chip for studying electric field-assisted wound-healing process,” Biomicrofluidics, vol. 6, no. 3, Article ID 034117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S.-Y. Wu, H.-S. Hou, Y.-S. Sun, J.-Y. Cheng, and K.-Y. Lo, “Correlation between cell migration and reactive oxygen species under electric field stimulation,” Biomicrofluidics, vol. 9, no. 5, Article ID 054120, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. E. D. Kirson, V. Dbalý, F. Tovaryš et al., “Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 104, no. 24, pp. 10152–10157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. C. Miranda, A. Mekonnen, R. Salvador, and P. J. Basser, “Predicting the electric field distribution in the brain for the treatment of glioblastoma,” Physics in Medicine and Biology, vol. 59, no. 15, pp. 4137–4147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. E. D. Kirson, Z. Gurvich, R. Schneiderman et al., “Disruption of Cancer Cell Replication by Alternating Electric Fields,” Cancer Research, vol. 64, no. 9, pp. 3288–3295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Gharaee, M. Habibpour, H. Sepehri, and L. Delphi, “10P Efficacy of tumor treating field therapy alone and in combination with doxorubicin in cellular model of breast cancer,” Annals of Oncology, vol. 27, no. suppl_9, 2016. View at Publisher · View at Google Scholar
  18. M. Giladi, U. Weinberg, R. S. Schneiderman et al., “Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo,” Seminars in Oncology, vol. 41, no. 6, pp. S35–S41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Munster, R. Blat, P. C. Roberts et al., “Abstract B79: Translational study of tumor treating fields in combination with paclitaxel in ovarian cancer.,” Clinical Cancer Research, vol. 22, no. 2 Supplement, pp. B79–B79, 2016. View at Publisher · View at Google Scholar
  20. J. Byrne, A. O'Neill, R. Jajja et al., “Electric-field assisted delivery of gemcitabine for the treatment of pancreatic cancer,” Cancer Research, vol. 73, no. 8 Supplement, pp. 5610–5610, 2014. View at Publisher · View at Google Scholar
  21. R. Stupp, E. T. Wong, A. A. Kanner et al., “NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality,” European Journal of Cancer, vol. 48, no. 14, pp. 2192–2202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. E. T. Wong, E. Lok, and K. D. Swanson, “Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: A preliminary observation,” Cancer Medicine, vol. 4, no. 3, pp. 383–391, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Stupp, “Tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM): Final results of a randomized, multi-center, phase III trial,” in Proceedings of the AACR Annual Meeting 2017, 2017.
  24. K. Nowak, E. Mix, J. Gimsa et al., “Optimizing a rodent model of parkinson's disease for exploring the effects and mechanisms of deep brain stimulation,” Parkinson’s Disease, vol. 2011, Article ID 414682, 19 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus